Patent · US Active

Platform for generating safe cell therapeutics

US12049644B2 · kind B2 · utility

0Cited by
15References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 11, 2021
Grant dateJul 30, 2024
Priority date—
Expiry dateAug 31, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2513/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are cytoplasts (enucleated cells), methods for making cytoplasts, compositions comprising cytoplasts, and methods for using cytoplasts.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.